Skip to main content

Table 3 Serum ferritin and TSAT responder analysis

From: Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data

  

   Number of

   Percent with

  

Outcome

Comparator

   Trials

   Patients

Ferric

carboxymaltose

   Control

RB

95% CI

NNT

95% CI

Target ferritin increase

All

   3

   611

   61

   43

   1.6 (1.3 to 1.9)

   5.6 (3.9 to 10)

 

Oral iron

   2

   428

   59

   22

   2.7 (2.0 to 3.6)

   2.7 (2.2 to 3.6)

Target TSAT increase

All

   3

   611

   65

   62

   1.1 (0.9 to 1.2)

   not calculated

 

Oral iron

   2

   428

   64

   59

   1.1 (0.9 to 1.3)

   not calculated